ADVERTISEMENT
Podcasts
Episode 2: BTK Inhibitors for CLL and Lymphomas
07/03/2020
On this episode of Blood Bytes, a hematology podcast produced by Oncology Learning Network, John Leonard, MD, Senior Associate Dean and Professor of Hematology/Oncology at Weill Cornell Medicine and NewYork-Presbyterian Hospital, and Richard Furman, MD, Distinguished Associate Professor of Medicine and Director of CLL Research at Weill Cornell Medicine, discuss BTK inhibitors for the treatment of CLL and lymphomas.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Visit the OLN Excellence Forums
Advertisement
Advertisement
Advertisement